Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

IDX/SURI stock hub

IDX/SURI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IDX/SURIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

532.1B

Indonesia Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IDX/SURI

In the news

Latest news · IDX/SURI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.4P50 14.4P75 23.9

Trailing P/En/a

P25 11.5P50 23.8P75 52.6

ROE-0.1

P25 0.6P50 5.1P75 12.2

ROIC-0.2

P25 1.3P50 6P75 11.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IDX/SURI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

186

Groups with data

Currency

IDR

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	143
Employees Change	-24%
Employees Change Percent	-14.37
Enterprise value	IDR 528.7B
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	ID1000200207
Last refreshed	2026-05-10
Market cap	IDR 532.1B
Price	IDR 84
Price currency	IDR
Rev Per Employee	1,207,753,776.75x
Sector	Healthcare
Sic	3842
Symbol	idx/SURI
Website	https://malgloves.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.03%
EV Earnings	-2,933.78x
EV/EBITDA	185.54x
EV/FCF	140.3x
EV/Sales	3.47x
FCF yield	0.71%
P/B ratio	1.55x
P/S ratio	3.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-0.44%
EBITDA Margin	1.51%
FCF margin	2.48%
Gross margin	8.41%
Gross Profit	IDR 12.8B
Gross Profit Growth	5.86%
Gross Profit Growth Q	142.56%
Gross Profit Growth3 Y	-37.44%
Net Income	IDR -180.2M
Net Income Growth Q	761.05%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-0.1%
Profit Margin	-0.12%
Profit Per Employee	IDR -1.4M
ROA	-0.11
Roa5y	1.68
ROCE	-0.19
ROE	-0.05
Roe5y	8.75
ROIC	-0.2
Roic5y	4.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	68.06%
EPS Growth Q	761.1
EPS Growth Quarters	2
EPS Growth Years	1
FCF Growth	-3.04%
FCF Growth Q	575.6%
FCF Growth3 Y	-25.23%
OCF Growth	-93.17%
OCF Growth Q	621.17%
OCF Growth3 Y	-25.23%
Revenue Growth	22.79x
Revenue Growth Q	5.69x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	-21.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	IDR 0.39
Assets	IDR 389.5B
Cash	IDR 4.8B
Current Assets	IDR 202.6B
Current Liabilities	IDR 40.6B
Debt	IDR 1.4B
Debt EBITDA	IDR 0.51
Debt Equity	IDR 0
Debt FCF	IDR 0.38
Equity	IDR 344.1B
Interest Coverage	-10.29
Liabilities	IDR 45.4B
Long Term Assets	IDR 186.9B
Long Term Liabilities	IDR 4.9B
Net Cash	IDR 3.4B
Net Cash By Market Cap	IDR 0.63
Net Cash Growth	821.4%
Net Debt EBITDA	IDR -1.47
Net Debt Equity	IDR -0.01
Net Debt FCF	IDR -0.89
Tangible Book Value	IDR 340B
Tangible Book Value Per Share	IDR 53.67
WACC	-0.78

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5
Inventory Turnover	2.36
Net Working Capital	IDR 158.4B
Quick ratio	1.31
Working Capital	IDR 162.1B
Working Capital Turnover	IDR 0.94

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	68%
200-day SMA	96.51
50-day SMA	71.34
50-day SMA vs 200-day SMA	50under200
All Time High	750
All Time High Change	-88.8%
All Time High Date	2024-02-19
All Time Low	50
All Time Low Change	68%
All Time Low Date	2024-11-29
ATR	7.63
Beta	-0.92
Beta1y	0.64
Beta2y	1.08
Ch YTD	-7.69
High	94
High52	152
High52 Date	2025-09-16
High52ch	-44.74%
Low	81
Low52	50
Low52 Date	2025-05-08
Low52ch	68%
Ma50ch	17.75%
Price vs 200-day SMA	-12.96%
RSI	61.56
RSI Monthly	46.85
RSI Weekly	50.54
Sharpe ratio	0.97x
Sortino ratio	1.88
Tr YTD	-7.69
Tr1m	27.27%
Tr1w	7.69%
Tr3m	7.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	IDR -676.8M
Operating Income Growth Q	686.9
Operating margin	-0.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	924,632,900%
Net Borrowing	-854,472,310
Shares Insiders	85.4%
Shares Out	6,334,375,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	IDR 3.8B
Average Volume	39,842,635x
Bv Per Share	54.32
CAPEX	IDR -1.2B
Ch1m	27.27
Ch1w	7.69
Ch1y	68
Ch3m	7.69
Ch6m	-18.45
Change	1.2%
Change From Open	2.44
Close	83
Days Gap	-1.2
Depreciation Amortization	2,967,180,050
Dollar Volume	14,206,575,600
Earnings Date	2026-05-26
EBIT	IDR -676.8M
EBITDA	IDR 2.3B
EPS	IDR -0.03
F Score	4
FCF	IDR 3.8B
FCF EV Yield	0.71x
FCF Per Share	IDR 0.59
Financing CF	-854,472,310
Fiscal Year End	December
Founded	1,988
Income Tax	IDR 35.3M
Investing CF	-1,231,715,410
Is Primary Listing	1
Last Earnings Date	2025-10-30
Last Report Date	2026-03-31
Ma150	89.5
Ma150ch	-6.15%
Ma20	76.1
Ma20ch	10.38%
Net CF	2,914,080,334
Next Earnings Date	2026-05-26
Open	82
P FCF Ratio	141.2
P OCF Ratio	106.4
Position In Range	23.08
Ppne	179,730,312,956
Price Date	2026-05-08
Price EBITDA	IDR 232
Ptbv Ratio	1.57
Relative Volume	5.37x
Revenue	152,176,975,870x
Tax By Revenue	0.02x
Tr6m	-18.45%
Volume	169,125,900

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IDX/SURI pay a dividend?

Capital-return profile for this ticker.

Performance

IDX/SURI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IDX/SURI?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+85.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

IDX/SURI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.6

Neutral momentum band

Price vs 200-day MA

-13.0%

50/200-day relationship not available

Beta (5Y)

-0.92

Less volatile than the market

Sharpe ratio

0.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IDX/SURI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/SURI stock rating?

idx/SURI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/SURI analysis?

The full report lives at /stocks/idx/SURI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/SURI?

The latest report frames idx/SURI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/SURI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.